{
  "docId": "019de073-416f-70a9-9a67-b7603aefb8d6",
  "docSlug": "920131855bb64d70700de092a3a107b0",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 50 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 12,
  "pageCount": 50,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 112,
  "notes": "The table is split into two main blocks: 2Q22 performance and YTD performance, with sub-totals for Bausch Pharma + Solta, Bausch+Lomb, and Total Bausch Health.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-416f-70a9-9a67-b7603aefb8d6/12",
  "deckHref": "/decks/019de073-416f-70a9-9a67-b7603aefb8d6",
  "deckJsonHref": "/decks/019de073-416f-70a9-9a67-b7603aefb8d6.json",
  "deckAnchorHref": "/decks/019de073-416f-70a9-9a67-b7603aefb8d6#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.28,
        "x": 0.675,
        "y": 0.925
      },
      "kind": "image",
      "text": "Bausch Health logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5a23a62-7769-463b-b330-0dbb2ef5e483",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.91,
        "x": 0.045,
        "y": 0.825
      },
      "kind": "subtitle",
      "text": "1. This is a non-GAAP measure or non-GAAP ratio. See Slide 3 and Non-GAAP Appendix for further information on non-GAAP measures and ratios. 2. Commencing in the first quarter of 2022, the Company operates in the following reportable segments: (i) Salix, (ii) International, (iii) Diversified Products, (iv) Solta Medical and (v) Bausch + Lomb. Also commencing in the first quarter of 2022, the Company moved certain products previously reported in the Dentistry business unit to the Ortho Dermatologics business unit and certain products previously reported in the Ortho Dermatologics business unit to the Generics business unit. 3. Bausch Pharma revenues, also referred to as Bausch Pharma + Solta revenues, is a non-GAAP measure, calculated by subtracting Bausch + Lomb segment revenues for the applicable period from total Bausch Health revenues for the applicable period.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a22c151-6ea0-45f6-a43d-020e39922364",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.91,
        "x": 0.045,
        "y": 0.185
      },
      "kind": "table",
      "text": "Revenue performance table with segments as rows and metrics (2Q22, 2Q21, Reported, Organic) as columns for both 2Q and YTD periods.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f2cfa0a-f570-42ce-ae45-04b62a3032e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.045,
        "y": 0.04
      },
      "kind": "title",
      "text": "Consolidated 2Q22/YTD Revenue performance",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fc6348b-730f-4a87-8640-76af943b184a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 8,
      "beatId": "ee7d4d1a-fc94-4c54-9fc5-b84c4a4074c1",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "The document provides detailed financial results, including revenue and GAAP financial results",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}